HY7718 supplementation was associated with reduced expression of genes related to renal fibrosis (<i>Col1a1</i>, <i>Acta2</i>) and vascular inflammation (<i>Icam-1</i>, <i>Vcam-1</i>). Here, COL1A1 is linked to renal fibrosis.